Skip to main content

Table 4 Baseline characteristics prior to hospitalization for 254 patients (ESBL-producing Enterobacteriaceae) and 233 controls (no ESBL-producing Enterobacteriaceae)

From: A prospective surveillance study for multidrug-resistant bacteria colonization in hospitalized patients at a Thai University Hospital

Baseline characteristics ESBL+
(N = 254)
ESBL-
(N = 233)
p-value
Mean age ± SD (years) 61.4 ± 18.2 61.9 ± 17.4 0.76
Male gender 120 (47.2%) 101 (43.4%) 0.39
Previous hospitalization 115 (45.3%) 96 (41.2%) 0.37
Transfer status
From another hospital 30 (11.8%) 26 (11.2%) 0.82
From a long-term care facility 4 (1.6%) 2 (0.9%) 0.47
Underlying diseases
Any underlying disease 225 (88.6%) 195 (83.7%) 0.12
Hypertension 115 (61.0%) 135 (57.9%) 0.49
Diabetes mellitus 106 (41.7%) 78 (33.5%) 0.06
Cardiovascular disease 74 (29.1%) 59 (25.3%) 0.35
Cerebrovascular disease 56 (22.0%) 41 (17.6%) 0.22
Chronic liver disease 43 (16.9%) 45 (19.3%) 0.50
Chronic renal disease 37 (14.6%) 27 (11.6%) 0.33
Chronic lung disease 32 (12.6%) 41 (17.6%) 0.82
Malignancy 46 (18.1%) 41 (17.6%) 0.88
Solid malignancy 42 (16.5%) 33 (14.1%) 0.47
Hematologic malignancy 4 (1.6%) 8 (3.4%) 0.19
Hematologic diseases 26 (10.2%) 21 (9.0%) 0.65
Prior organ transplantation 2 (0.8%) 5 (2.2%) 0.21
Receipt of any immunosuppressive agent 33 (13.0%) 26 (11.2%) 0.54
HIV infection 10 (3.9%) 6 (2.6%) 0.40
Previous antibiotic exposure within 90 days after hospitalization
 Any antibiotic 84 (33.1%) 64 (27.5%) 0.18
 Penicillins 12 (4.7%) 7 (3.0%) 0.33
 Cephalosporins 40 (15.8%) 20 (8.6%) 0.02
 Carbapenems 16 (6.3%) 17 (7.3%) 0.67
 Beta-lactam/beta-lactamase inhibitors 10 (3.9%) 17 (7.3%) 0.11
 Fluoroquinolones 26 (10.2%) 20 (8.6%) 0.53
 Macrolides 11 (4.3%) 8 (3.4%) 0.61
 Others 24 (9.5%) 18 (7.7%) 0.50
Previous use of indwelling catheters
 Urinary catheter 40 (15.8%) 33 (14.2%) 0.63
 Nasogastric tube 26 (10.2%) 19 (8.2%) 0.43